Skip to NavigationSkip to content

News

Ascletis begins Phase III trial into bevacizumab for treatment of recurrent glioblastoma
Ascletis Pharma has announced the dosing of the first patient in the Phase III registration clinical trial of ASC40, combined with bevacizumab, for...
Pfizer: Annual COVID shots preferable to frequent boosters
Pfizer CEO Albert Bourla has commented that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the pandemic.
NICE expands guidance for lokelma in adult patients with persistent hyperkalaemia
NICE have updated the Technology Appraisal Guidance (TAG) for Lokelma (sodium zirconium cyclosilicate SZC) in the treatment of adult patients with...
Veklury obtains FDA approval for COVID-19 outpatients
The FDA has granted expedited approval of a supplemental new drug application (sNDA) for Veklury (remdesivir) for he treatment of non-hospitalised...
>> More News Stories

Features

Maintaining product authenticity: The solution to a serial problem

While the pharmaceutical spotlight has shined brightest for COVID-19 vaccines and treatments, the undertone of counterfeit medicines...

>> More Features

Appointments

Julie Beeso joins Envision Pharma Group as new Global Director

Envision Pharma Group has appointed Julie Beeso as its Global Director, Professional Development and Engagement. Julie has worked for almost 25...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches